Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention Outcome Measures

0
140

Opportunity ID: 328398
Opportunity Number: RFA-DD-21-002
Opportunity Title: Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention Outcome Measures
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.315
Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:
Agency Code: HHS-CDC-HHSCDCERA
Agency Name: Department of Health and Human Services
Centers for Disease Control and Prevention – ERA
Posted Date: Jul 29, 2020
Last Updated Date: Jul 29, 2020
Estimated Synopsis Post Date: Nov 10, 2020
Fiscal Year: 2021
Award Ceiling: $700,000
Award Floor: $0
Estimated Total Program Funding: $3,500,000
Expected Number of Awards: 1
Description: The purpose of this NOFO is to conduct research to better characterize the natural history of fragile X syndrome (FXS) and meaningful outcome measures in order to improve the lives of children and adolescents with FXS with and without autism spectrum disorder (ASD). The funding will support enrollment and in-person standardized assessments of individuals aged 6 through 19 years with full-mutation FXS, which can include new and previously enrolled study participants of the Fragile X Online Registry with Accessible Research Database (FORWARD). FORWARD is a national registry of patients enrolled in FXS specialty clinics who are part of the Fragile X Clinical and Research Consortium. Data collection will include assessments to characterize the cognitive, behavioral, and adaptive skills, and other indicators of functioning of individuals with FXS. Planned coordination of standardized in-person behavioral and functional assessments and follow-up telephone survey questionnaires with CDC’s Study to Explore Early Development (SEED) Follow-up Study (RFA-DD21-001) will facilitate comparison of health and functional outcomes for the FXS population with those for other related and frequently co-occurring conditions such as ASD and developmental delay. Applicants may propose recruiting study participants from an individual FORWARD clinic, or recruiting from a group of FORWARD clinics with which the principal investigator has documented data sharing and collaborative agreements.
Version: 1





Visit the Official Webpage For More Details on Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention Outcome Measures

LEAVE A REPLY

Please enter your comment!
Please enter your name here